Patient Guide: A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Crovalimab Versus Eculizumab in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Currently Treated With Complement Inhibitors

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 83 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT04432584
Status: ACTIVE_NOT_RECRUITING
Condition: Paroxysmal Nocturnal Hemoglobinuria
Phase: PHASE3

Where You Can Participate

This study is available at 83 locations across the country.

Top locations include:
  • • Charlotte, North Carolina
  • • Columbus, Ohio
  • • Brussels,
  • • And 80 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Crovalimab Versus Eculizumab in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Currently Treated With Complement Inhibitors - Join Clinical Trial NCTNCT04432584

How to Join This Clinical Trial - NCTNCT04432584

Learn how to participate in this PHASE3 trial studying an investigational therapy for Paroxysmal Nocturnal Hemoglobinuria. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Paroxysmal Nocturnal Hemoglobinuria. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Paroxysmal Nocturnal Hemoglobinuria
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT04432584 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 83 locations. Find a study site near you:

Clinical Research Site

Charlotte, North Carolina 28204 - United States

Status: Contact for availability

Clinical Research Site

Columbus, Ohio 43205 - United States

Status: Contact for availability

Clinical Research Site

Brussels, 1200 - Belgium

Status: Contact for availability

Clinical Research Site

Roeselare, 8800 - Belgium

Status: Contact for availability

Clinical Research Site

Yvoir, 5530 - Belgium

Status: Contact for availability

Clinical Research Site

Taguatinga, Federal District 72145-450 - Brazil

Status: Contact for availability

Clinical Research Site

Porto Alegre, Rio Grande do Sul 90020-090 - Brazil

Status: Contact for availability

Clinical Research Site

Porto Alegre, Rio Grande do Sul 90035-903 - Brazil

Status: Contact for availability

Clinical Research Site

Joinville, Santa Catarina 89201-260 - Brazil

Status: Contact for availability

Clinical Research Site

Ribeirão Preto, São Paulo 14048-900 - Brazil

Status: Contact for availability

And 73 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Paroxysmal Nocturnal Hemoglobinuria:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships